• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估突破性癌痛的影响。

Assessing the impact of breakthrough cancer pain.

作者信息

Burton Beth, Zeppetella Giovambattista

出版信息

Br J Nurs. 2011;20(10):S14, S16-9. doi: 10.12968/bjon.2011.20.10.S14.

DOI:10.12968/bjon.2011.20.10.S14
PMID:21647006
Abstract

Breakthrough pain is a transient exacerbation of pain that occurs either spontaneously or in relation to a specific predictable or unpredictable trigger despite relative stable and adequately controlled background pain. Breakthrough pain is a common and distinct component of cancer pain and is typically of rapid onset, severe in intensity, and generally self-limiting with an average duration of 30-60minutes. Despite the self-limiting nature of breakthrough pain, it can place significant physical, psychological, and economic burdens on both patients and their carers. Patients with breakthrough pain are often less satisfied with their analgesic therapy, they have decreased functioning because of their pain, and may also experience social and psychosocial consequences, such as increased levels of anxiety and depression. Successful management of breakthrough pain is best achieved by a thorough assessment which includes determining the severity, pathophysiology, and aetiology of the pain and takes into account both background and breakthrough pains while considering whether the underlying disease, co-morbidities or precipitating events are amenable to interventions. The features of breakthrough pain and the challenges it presents to patients, their carers, and health professionals are illustrated with a case study.

摘要

爆发性疼痛是疼痛的一种短暂加剧,它可自发出现,或在背景疼痛相对稳定且得到充分控制的情况下,与特定的可预测或不可预测的触发因素相关。爆发性疼痛是癌痛常见且独特的组成部分,通常起病迅速,强度剧烈,一般为自限性,平均持续时间为30 - 60分钟。尽管爆发性疼痛具有自限性,但它会给患者及其护理人员带来巨大的身体、心理和经济负担。患有爆发性疼痛的患者通常对其镇痛治疗的满意度较低,他们因疼痛而功能下降,还可能经历社会和心理社会方面的后果,如焦虑和抑郁水平升高。成功管理爆发性疼痛最好通过全面评估来实现,评估包括确定疼痛的严重程度、病理生理学和病因,并在考虑潜在疾病、合并症或诱发事件是否适合干预的同时,兼顾背景疼痛和爆发性疼痛。通过一个案例研究来说明爆发性疼痛的特征及其给患者、其护理人员和医疗专业人员带来的挑战。

相似文献

1
Assessing the impact of breakthrough cancer pain.评估突破性癌痛的影响。
Br J Nurs. 2011;20(10):S14, S16-9. doi: 10.12968/bjon.2011.20.10.S14.
2
Impact and management of breakthrough pain in cancer.癌症中爆发痛的影响与管理
Curr Opin Support Palliat Care. 2009 Mar;3(1):1-6. doi: 10.1097/SPC.0b013e3283260658.
3
Breakthrough pain in cancer patients.癌症患者的爆发性疼痛。
Clin Oncol (R Coll Radiol). 2011 Aug;23(6):393-8. doi: 10.1016/j.clon.2010.12.002. Epub 2011 Jan 11.
4
Opioids for the management of breakthrough pain in cancer patients.用于治疗癌症患者爆发性疼痛的阿片类药物。
Cochrane Database Syst Rev. 2013 Oct 21(10):CD004311. doi: 10.1002/14651858.CD004311.pub3.
5
Fentanyl sublingual spray for breakthrough pain in cancer patients.芬太尼舌下喷雾剂治疗癌症患者爆发性疼痛。
Pain Ther. 2013 Jun;2(1):1-9. doi: 10.1007/s40122-013-0008-9. Epub 2013 Feb 19.
6
Opioids for the management of breakthrough (episodic) pain in cancer patients.用于治疗癌症患者爆发性(间歇性)疼痛的阿片类药物。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004311. doi: 10.1002/14651858.CD004311.pub2.
7
Dynamics of breakthrough pain vs. pharmacokinetics of oral morphine: implications for management.爆发痛的动力学与口服吗啡的药代动力学:对管理的影响。
Eur J Cancer Care (Engl). 2009 Jul;18(4):331-7. doi: 10.1111/j.1365-2354.2008.01009.x. Epub 2009 Mar 23.
8
A survey of Canadian cancer patients' perspectives on the characteristics and treatment of breakthrough pain.加拿大癌症患者对爆发性疼痛的特征和治疗的看法调查。
Support Care Cancer. 2013 Sep;21(9):2557-63. doi: 10.1007/s00520-013-1817-4. Epub 2013 May 2.
9
Cultural adaptation and psychometric validation of the Portuguese breakthrough pain assessment tool with cancer patients.葡萄牙癌症患者爆发性疼痛评估工具的文化适应性及心理测量学验证
Scand J Pain. 2021 May 3;21(4):688-695. doi: 10.1515/sjpain-2021-0002. Print 2021 Oct 26.
10
Breakthrough pain: characteristics and impact in patients with cancer pain.爆发性疼痛:癌症疼痛患者的特征及影响
Pain. 1999 May;81(1-2):129-34. doi: 10.1016/s0304-3959(99)00006-8.

引用本文的文献

1
A rapid systematic review of breakthrough pain definitions and descriptions.突破性疼痛定义与描述的快速系统评价
Br J Pain. 2024 Jun;18(3):215-226. doi: 10.1177/20494637231208093. Epub 2023 Dec 25.
2
Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study.埃塞俄比亚北部肿瘤科室癌症患者的爆发性疼痛;一项多中心研究。
Front Oncol. 2024 Jan 9;13:1248921. doi: 10.3389/fonc.2023.1248921. eCollection 2023.
3
Family Caregiver Challenges in Pain Management for Patients with Advanced Illnesses: A Systematic Review.
晚期疾病患者疼痛管理中家庭护理人员面临的挑战:系统评价。
J Palliat Med. 2022 Dec;25(12):1865-1876. doi: 10.1089/jpm.2020.0806. Epub 2022 Sep 29.
4
Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.加泰罗尼亚教学医院门诊中突破性癌痛的流行情况和特征:将癌症疼痛的埃德蒙顿分类系统纳入诊断算法。
BMC Palliat Care. 2018 May 28;17(1):81. doi: 10.1186/s12904-018-0336-y.
5
Development and performance of a diagnostic/prognostic scoring system for breakthrough pain.突破性疼痛诊断/预后评分系统的开发与性能
J Pain Res. 2017 May 31;10:1327-1335. doi: 10.2147/JPR.S126132. eCollection 2017.
6
Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).突破性癌痛的诊断与管理:所有问题都解决了吗?基于德尔菲法的共识评估(DOIRON)
Clin Transl Oncol. 2016 Sep;18(9):945-54. doi: 10.1007/s12094-015-1468-7. Epub 2015 Dec 22.
7
Breakthrough pain in patients with controlled or uncontrolled basal pain: an observational study.基础疼痛得到控制或未得到控制的患者的爆发性疼痛:一项观察性研究。
Pain Res Manag. 2014 Nov-Dec;19(6):e168-71. doi: 10.1155/2014/646312. Epub 2014 Jun 19.
8
Single-dose fentanyl sublingual spray for breakthrough cancer pain.单剂量芬太尼舌下喷雾剂用于治疗癌症突破性疼痛。
Clin Pharmacol. 2013 Jul 24;5:131-41. doi: 10.2147/CPAA.S26649. Print 2013.
9
Considerations in selecting rapid-onset opioids for the management of breakthrough pain.考虑选择快速起效的阿片类药物来管理爆发性疼痛。
J Pain Res. 2013;6:189-200. doi: 10.2147/JPR.S40745. Epub 2013 Mar 6.